SK283625B6 - Spôsob prípravy 2,4-dihydroxypyridínu - Google Patents

Spôsob prípravy 2,4-dihydroxypyridínu Download PDF

Info

Publication number
SK283625B6
SK283625B6 SK906-98A SK90698A SK283625B6 SK 283625 B6 SK283625 B6 SK 283625B6 SK 90698 A SK90698 A SK 90698A SK 283625 B6 SK283625 B6 SK 283625B6
Authority
SK
Slovakia
Prior art keywords
adenosine
thienyl
ethyl
compounds
chloro
Prior art date
Application number
SK906-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK90698A3 (en
Inventor
Larry K. Truesdale
James P. Sherbine
Benoit J. Vanasse
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of SK90698A3 publication Critical patent/SK90698A3/sk
Publication of SK283625B6 publication Critical patent/SK283625B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SK906-98A 1996-01-02 1996-12-23 Spôsob prípravy 2,4-dihydroxypyridínu SK283625B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US949296P 1996-01-02 1996-01-02
PCT/US1996/020768 WO1997024327A1 (en) 1996-01-02 1996-12-23 Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine

Publications (2)

Publication Number Publication Date
SK90698A3 SK90698A3 (en) 2000-12-11
SK283625B6 true SK283625B6 (sk) 2003-10-07

Family

ID=21737998

Family Applications (1)

Application Number Title Priority Date Filing Date
SK906-98A SK283625B6 (sk) 1996-01-02 1996-12-23 Spôsob prípravy 2,4-dihydroxypyridínu

Country Status (22)

Country Link
US (2) US6307054B1 (cs)
EP (1) EP0909270B1 (cs)
JP (1) JP2000502709A (cs)
KR (1) KR19990076966A (cs)
AP (1) AP772A (cs)
AT (1) ATE219767T1 (cs)
AU (1) AU722894B2 (cs)
BR (1) BR9612341A (cs)
CA (1) CA2241887C (cs)
CZ (1) CZ203998A3 (cs)
DE (1) DE69622051T2 (cs)
DK (1) DK0909270T3 (cs)
EA (1) EA000884B1 (cs)
ES (1) ES2178725T3 (cs)
HK (1) HK1019590A1 (cs)
HU (1) HUP9900969A3 (cs)
IL (1) IL125164A (cs)
OA (1) OA10803A (cs)
PT (1) PT909270E (cs)
SI (1) SI9620137B (cs)
SK (1) SK283625B6 (cs)
WO (1) WO1997024327A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2228163T3 (es) 1998-12-31 2005-04-01 Aventis Pharmaceuticals Inc. Procedimiento para preparar derivados de desaza-adenosina n6-sustituidos.
US7018365B2 (en) 1999-05-21 2006-03-28 Micro Therapeutics, Inc. Threaded syringe with quick stop
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US7291603B2 (en) 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
CA2523746A1 (en) * 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
WO2005025545A2 (en) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Pharmaceutical formulation for controlled release of selodenoson
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
PL2322525T3 (pl) 2006-04-21 2014-03-31 Novartis Ag Pochodne puryny do zastosowania jako agoniści receptora adenozyny A<sub>2A</sub>
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) * 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
CN101553459A (zh) * 2006-11-10 2009-10-07 诺瓦提斯公司 环戊烯二醇单乙酸酯衍生物
WO2010089773A2 (en) 2009-02-02 2010-08-12 Indoco Remedies Limited Process for preparation of nitropyridine derivatives
CN114349873B (zh) * 2021-04-12 2023-03-17 杭州安誉科技有限公司 用于多孔模块辅助控制装置的高强度风扇支架

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3547935A (en) * 1967-08-07 1970-12-15 American Cyanamid Co Certain nitro-4-pyridinols,n-oxides thereof and derivatives thereof
GB1199699A (en) * 1968-01-08 1970-07-22 Glanzstoff Ag Process for the Production of Condensed Aromatic Bis-(2,4-Dihydroxypyridine) Derivatives
DE3308449A1 (de) * 1982-08-19 1984-03-15 Rütgerswerke AG, 6000 Frankfurt Verfahren zur reindarstellung von 2-chlor-6-alkoxy-3-nitropyridinen
JP3261190B2 (ja) * 1993-01-27 2002-02-25 広栄化学工業株式会社 2−ヒドロキシ−3,5−ジニトロピリジン類の製造法

Also Published As

Publication number Publication date
ATE219767T1 (de) 2002-07-15
CZ203998A3 (cs) 1999-11-17
KR19990076966A (ko) 1999-10-25
OA10803A (en) 2003-01-28
DE69622051D1 (de) 2002-08-01
SI9620137A (sl) 1999-02-28
IL125164A0 (en) 1999-01-26
CA2241887A1 (en) 1997-07-10
IL125164A (en) 2003-03-12
EP0909270A1 (en) 1999-04-21
US6307054B1 (en) 2001-10-23
WO1997024327A1 (en) 1997-07-10
AU1354697A (en) 1997-07-28
ES2178725T3 (es) 2003-01-01
AU722894B2 (en) 2000-08-10
AP9801289A0 (en) 1998-09-30
HUP9900969A3 (en) 2001-11-28
DE69622051T2 (de) 2003-01-23
JP2000502709A (ja) 2000-03-07
AP772A (en) 1999-10-15
DK0909270T3 (da) 2002-10-07
US6392049B1 (en) 2002-05-21
SK90698A3 (en) 2000-12-11
HK1019590A1 (en) 2000-02-18
BR9612341A (pt) 1999-12-28
EA000884B1 (ru) 2000-06-26
EP0909270A4 (cs) 1999-04-21
SI9620137B (sl) 2006-02-28
PT909270E (pt) 2002-11-29
HUP9900969A2 (hu) 1999-07-28
EA199800621A1 (ru) 1999-02-25
CA2241887C (en) 2004-02-24
EP0909270B1 (en) 2002-06-26

Similar Documents

Publication Publication Date Title
EP0758897B1 (en) Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5652366A (en) DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
AU654507B2 (en) Compounds having antihypertensive and anti-ischemic properties
CA2241887C (en) Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine
CZ291785B6 (cs) Adenosinový derivát a jeho použití a farmaceutická kompozice s jeho obsahem